FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213081657> ?p ?o ?g. }

• W4213081657 endingPage "1229" @default.
• W4213081657 startingPage "1227" @default.
• W4213081657 abstract "Patients with heart failure (HF) have poor prognoses despite substantial advances in therapeutic development. Comprehensive guideline-directed medical therapy (GDMT) is infrequently achieved in practice, especially at target doses. 1 Greene SJ Fonarow GC DeVore AD Sharma PP Vaduganathan M Albert NM et al. Titration of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019; (21): 2365-2383 Google Scholar The effects of GDMT on hemodynamic, electrolyte and renal parameters limit clinicians’ eagerness to initiate and titrate these drugs. Indeed, the most common reason for the inability to achieve target GDMT is that a patient is on “maximally tolerated” therapy. 2 Fiuzat M Ezekowitz J Alemayehu W Westerhout CM Sbolli M Cani D et al. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT Trial: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2020; 5: 757-764 Google Scholar GDMT intolerance is associated with particularly unfavorable outcomes. 3 Morris AA Khazanie P Drazner MH Albert NM Breathett K Cooper LB et al. Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2021; 144: e238-e250 Google Scholar Whether this is related to fragile hemodynamic status, lack of exposure to beneficial therapies, or some combination of the 2 has not been fully elucidated. Some patients who have this clinical profile are eligible for advanced therapies, but the vast majority will not undergo cardiac replacement. 4 Truby LK Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail. 2020; 8: 523-536 Google Scholar ,5 Birks EJ Drakos SG Patel SR Lowes BD Selzman CH Starling RC et al. Prospective multicenter study of myocardial recovery using left ventricular assist devices (RESTAGE-HF [Remission from Stage D Heart Failure]): medium-term and primary end point results. Circulation. 2020; 142: 2016-2028 Google Scholar Thus, there is an ongoing need for strategies that can facilitate GDMT tolerance. Drug therapies have long been used to facilitate tolerance of beneficial devices (eg, dual antiplatelet therapy after percutaneous coronary intervention) and other drugs (eg, potassium binders to facilitate renin-angiotensin-aldosterone system inhibitor use), but most cardiac devices have not been intentionally applied to facilitate tolerance of beneficial drugs (Fig. 1), some notable exceptions being myocardial recovery in patients with durable mechanical circulatory support (MCS)5 and pacemaker implantation to facilitate beta-blocker tolerance for arrhythmia management." @default.
• W4213081657 created "2022-02-24" @default.
• W4213081657 creator A5022314919 @default.
• W4213081657 creator A5061881316 @default.
• W4213081657 creator A5074426285 @default.
• W4213081657 date "2022-07-01" @default.
• W4213081657 modified "2023-09-25" @default.
• W4213081657 title "The Enabling Potential of Device Therapy for Heart Failure" @default.
• W4213081657 cites W2919920736 @default.
• W4213081657 cites W3017169845 @default.
• W4213081657 cites W3034270991 @default.
• W4213081657 cites W3107163751 @default.
• W4213081657 cites W3196631458 @default.
• W4213081657 doi "https://doi.org/10.1016/j.cardfail.2022.02.005" @default.
• W4213081657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35172221" @default.
• W4213081657 hasPublicationYear "2022" @default.
• W4213081657 type Work @default.
• W4213081657 citedByCount "0" @default.
• W4213081657 crossrefType "journal-article" @default.
• W4213081657 hasAuthorship W4213081657A5022314919 @default.
• W4213081657 hasAuthorship W4213081657A5061881316 @default.
• W4213081657 hasAuthorship W4213081657A5074426285 @default.
• W4213081657 hasConcept C126322002 @default.
• W4213081657 hasConcept C142724271 @default.
• W4213081657 hasConcept C164705383 @default.
• W4213081657 hasConcept C168563851 @default.
• W4213081657 hasConcept C177713679 @default.
• W4213081657 hasConcept C178853913 @default.
• W4213081657 hasConcept C2778198053 @default.
• W4213081657 hasConcept C2780182762 @default.
• W4213081657 hasConcept C2994510025 @default.
• W4213081657 hasConcept C535046627 @default.
• W4213081657 hasConcept C71924100 @default.
• W4213081657 hasConcept C78085059 @default.
• W4213081657 hasConceptScore W4213081657C126322002 @default.
• W4213081657 hasConceptScore W4213081657C142724271 @default.
• W4213081657 hasConceptScore W4213081657C164705383 @default.
• W4213081657 hasConceptScore W4213081657C168563851 @default.
• W4213081657 hasConceptScore W4213081657C177713679 @default.
• W4213081657 hasConceptScore W4213081657C178853913 @default.
• W4213081657 hasConceptScore W4213081657C2778198053 @default.
• W4213081657 hasConceptScore W4213081657C2780182762 @default.
• W4213081657 hasConceptScore W4213081657C2994510025 @default.
• W4213081657 hasConceptScore W4213081657C535046627 @default.
• W4213081657 hasConceptScore W4213081657C71924100 @default.
• W4213081657 hasConceptScore W4213081657C78085059 @default.
• W4213081657 hasFunder F4320306257 @default.
• W4213081657 hasFunder F4320315432 @default.
• W4213081657 hasFunder F4320332161 @default.
• W4213081657 hasFunder F4320332558 @default.
• W4213081657 hasFunder F4320337338 @default.
• W4213081657 hasIssue "7" @default.
• W4213081657 hasLocation W42130816571 @default.
• W4213081657 hasLocation W42130816572 @default.
• W4213081657 hasOpenAccess W4213081657 @default.
• W4213081657 hasPrimaryLocation W42130816571 @default.
• W4213081657 hasRelatedWork W2051712573 @default.
• W4213081657 hasRelatedWork W2091139515 @default.
• W4213081657 hasRelatedWork W2319805938 @default.
• W4213081657 hasRelatedWork W2326246478 @default.
• W4213081657 hasRelatedWork W2355594703 @default.
• W4213081657 hasRelatedWork W3033076790 @default.
• W4213081657 hasRelatedWork W3155674270 @default.
• W4213081657 hasRelatedWork W3187572025 @default.
• W4213081657 hasRelatedWork W4323040546 @default.
• W4213081657 hasRelatedWork W4382048704 @default.
• W4213081657 hasVolume "28" @default.
• W4213081657 isParatext "false" @default.
• W4213081657 isRetracted "false" @default.
• W4213081657 workType "article" @default.